Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Bio-Works Technologies

1.63

 

SEK

 

+1.87 %

Less than 1K followers

BIOWKS

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Ownership
Investor consensus
Compare
+1.87%
+23.02%
+29.65%
+69.26%
+91.79%
+0.3%
-87.84%
-69.01%
-81.03%

Bio-Works Technologies is a biotechnology company. The company develops products that separate and purify molecules in the production of drugs. The technology is based on chromatography that aims to handle the drug substance. Customers are found in the European market where products are sold through distribution partners and to companies in the pharmaceutical industry. They are also sold to research institutes and universities. The company was founded in 2006 and is headquartered in Uppsala.

Read more
Market cap
128.34M SEK
Turnover
217.2K SEK
Revenue
25.47M
EBIT %
-149.2 %
P/E
-
Dividend yield-%
-
Financial calendar
22.8
2025

Interim report Q2'25

20.2
2026

Annual report '25

All
Press releases
ShowingAll content types
Regulatory press release5/16/2025, 1:09 PM

Bio-Works Technologies AB: Correction to press release sent our yesterday

Bio-Works Technologies
Regulatory press release5/15/2025, 1:02 PM

Bio-Works Technologies AB: Bio-Works receives WorkBeads order worth SEK 2.5 million

Bio-Works Technologies
Regulatory press release5/15/2025, 8:30 AM

Bio-Works Technologies AB: Resolutions passed at Bio-Works Technologies' annual general meeting 2025

Bio-Works Technologies

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/15/2025, 5:00 AM

Bio-Works Technologies AB: Bio-Works reports first quarter 2025

Bio-Works Technologies
Regulatory press release4/29/2025, 2:04 PM

Bio-Works Technologies AB: Bio-Works Receives Order Worth SEK 2.4 Million from New European Customer in Vaccine Production

Bio-Works Technologies
Regulatory press release4/15/2025, 3:00 PM

Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 2 of 11

Bio-Works Technologies
Regulatory press release4/14/2025, 2:27 PM

Bio-Works Technologies AB: Bio-Works receives SEK 12 million order from global pharmaceutical company - delivery scheduled for 2026

Bio-Works Technologies
Regulatory press release4/1/2025, 6:00 AM

Today is the first day of the second exercise period for Bio-Works Technologies AB's warrants of series TO 2

Bio-Works Technologies
Regulatory press release3/27/2025, 3:02 PM

Bio-Works Technologies AB: Bio-Works Receives New Orders for Custom GoBio Columns for the U.S. Gene Therapy Market

Bio-Works Technologies
Regulatory press release2/26/2025, 1:49 PM

Bio-Works Technologies AB: Bio-Works Receives Order for WorkBeads Worth 2.65 Million SEK

Bio-Works Technologies
Regulatory press release2/21/2025, 7:00 AM

Bio-Works Technologies AB: Bio-Works publishes year-end report Q4 2024

Bio-Works Technologies
Press release2/14/2025, 11:46 AM

Bio-Works Technologies AB: Bio-Works Technologies Doubles Production Capacity to Meet Growing Demand

Bio-Works Technologies
Regulatory press release2/10/2025, 10:54 AM

Bio-Works Technologies AB: Bio-Works receives a third follow-up order for WorkBeads affimAb worth SEK 4.0 million

Bio-Works Technologies
Regulatory press release1/31/2025, 12:24 PM

Bio-Works Technologies AB: Bio-Works Receives Follow-Up Order for WorkBeads affimAb Worth 4.6 MSEK

Bio-Works Technologies
Regulatory press release1/14/2025, 12:33 PM

Bio-Works Technologies AB: Bio-Works Confirms a New Order for WorkBeads affimAb for Use in Antibody Production for 11.2 MSEK

Bio-Works Technologies
Regulatory press release1/2/2025, 10:39 AM

The first day to exercise Bio-Works Technologies AB's warrants of series TO 2 is today

Bio-Works Technologies
Regulatory press release11/12/2024, 5:21 PM

Bio-Works Technologies AB: Letter of Intent for order of WorkBreads affimAb increased to 11,9 Mkr

Bio-Works Technologies
Regulatory press release11/6/2024, 6:50 AM

Bio-Works publishes Q3 report 2024

Bio-Works Technologies
Press release11/4/2024, 3:30 PM

Bio-Works comfirms an order from Nemysis Ltd worth 2.2 MSEK

Bio-Works Technologies
Regulatory press release11/4/2024, 8:50 AM

Bio-Works receives a Letter of Intent (LOI) - the anticipated order value is €652,000.

Bio-Works Technologies
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team